Cantor Fitzgerald Reiterates Overweight on Johnson & Johnson, Maintains $215 Price Target

Analyst Upgrades20:50

Johnson & Johnson Analyst Ratings

Benzinga20:48 · Ratings

Johnson & Johnson Marks 50 Years In Singapore With Range Of Events

Bernama11:40

Novartis' Pluvicto Expected to Dominate Prostate Cancer Radiopharmaceutical Market

Seeking AlphaSep 22 04:00

Is Johnson & Johnson (JNJ) the Best Future Stock For The Long-Term?

Yahoo FinanceSep 21 18:41

Express News | Johnson & Johnson subsidiary applies for bankruptcy protection due to talcum powder-caused cancer issues.

BreakingsSep 21 08:34